Published in Cancer Res on February 01, 1982
Phenotype and genotype of pancreatic cancer cell lines. Pancreas (2010) 3.06
A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch (2003) 2.53
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
Do you know the sex of your cells? Am J Physiol Cell Physiol (2013) 1.49
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. J Biol Chem (2008) 1.31
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer (1987) 1.30
Current status of mucins in the diagnosis and therapy of cancer. Biofactors (2009) 1.17
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat Genet (2017) 1.08
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. Virchows Arch (2004) 1.05
Glycans related to the CA19-9 antigen are elevated in distinct subsets of pancreatic cancers and improve diagnostic accuracy over CA19-9. Cell Mol Gastroenterol Hepatol (2016) 1.02
Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters. Am J Pathol (1991) 0.96
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype. Br J Cancer (1991) 0.95
MUC4 mucin expression in human pancreatic tumours is affected by organ environment: the possible role of TGFbeta2. Br J Cancer (2004) 0.89
Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters. Am J Pathol (1990) 0.88
FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer (2001) 0.87
Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel) (2010) 0.86
Measurement of protein kinase B activity in single primary human pancreatic cancer cells. Anal Chem (2014) 0.84
Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins. J Proteome Res (2015) 0.82
Clinicohistopathologic and immunohistochemical studies of intrapancreatic development of carcinoma of the head of the pancreas. Ann Surg (1989) 0.82
Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A. Mol Cell Proteomics (2015) 0.79
The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities. Adv Cancer Res (2015) 0.79
An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease. Br J Cancer (1990) 0.78
Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors. Am J Pathol (1992) 0.78
Reactivity of monoclonal anti-human pancreatic carcinoma antibodies AR2-20 and AR1-28 with tumors of nonpancreatic origin. Am J Pathol (1987) 0.78
Altered expression of sialylated carbohydrate antigens in HT29 colonic carcinoma cells. Glycoconj J (1998) 0.77
The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes. Br J Cancer (1985) 0.77
Carcinoma of the pancreas. Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody. Ann Surg (1985) 0.76
Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells. Oncol Lett (2016) 0.75
The small heat shock protein αA-crystallin negatively regulates pancreatic tumorigenesis. Oncotarget (2016) 0.75
Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells. BMC Cancer (2016) 0.75
Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report. J Med Case Rep (2016) 0.75
Xanthogranulomatous cholecystitis expressing high levels of DUPAN-II. J Gastroenterol (2007) 0.75
Tumor cells interact with red blood cells via galectin-4 - a short report. Cell Oncol (Dordr) (2017) 0.75
Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol (1986) 3.65
Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med (2001) 3.60
Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes. J Immunol (1973) 3.45
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol (1993) 3.41
A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant. J Virol (2000) 2.37
Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem (1990) 2.22
Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 2.11
Acute bilineal leukemia: a rare disease with poor outcome. Leukemia (2007) 1.98
Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res (1994) 1.90
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med (1981) 1.85
Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes. Leukemia (2006) 1.74
Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med (1981) 1.74
Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood (1996) 1.70
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med (1988) 1.67
Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol (2000) 1.66
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): a Pediatric Oncology Group Study. Leukemia (2000) 1.60
Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58
Laboratory correlates and prognostic significance of granular acute lymphoblastic leukemia in children. A Pediatric Oncology Group study. Am J Clin Pathol (1991) 1.52
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma. Bone Marrow Transplant (1998) 1.51
Blood donation by the elderly. Clinical and policy considerations. JAMA (1987) 1.45
Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol (1995) 1.44
Flow cytometry in the diagnosis of acute leukemia. Semin Hematol (2001) 1.42
Identification of human T cell leukemia virus in a Japanese patient with adult T cell leukemia and cutaneous lymphomatous vasculitis. Proc Natl Acad Sci U S A (1983) 1.41
Purification of human interleukin 1. J Supramol Struct (1980) 1.38
Ret-Y a measure of reticulocyte size: a sensitive indicator of iron deficiency anemia. Clin Lab Haematol (2004) 1.38
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
Human T cell antigen expression by primate T cells. Science (1982) 1.35
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny. J Exp Med (1983) 1.35
Detection of HLA-DRw (Ia-like) antigens on human T lymphocytes grown in tissue culture. J Immunol (1979) 1.33
Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci U S A (1984) 1.33
Comparative stereology of the mouse and finch left ventricle. Tissue Cell (1978) 1.27
Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells. Cell Immunol (1978) 1.25
A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia (1999) 1.22
Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Cancer Res (1985) 1.16
Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. J Natl Cancer Inst (1984) 1.11
Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med (2001) 1.10
NIH conference. Airway inflammation. Ann Intern Med (1995) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Molecular cloning and sequence analysis of the human ribosomal protein S16. J Biol Chem (1991) 1.07
Non-specific and specific immunotherapy in patients with melanoma. Surgery (1972) 1.06
In vitro studies of the response of hamster lymphocytes to phytohemagglutinin and antigenic stimulation. J Immunol (1971) 1.06
Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res (1979) 1.05
The study of normal and malignant cell antigens by mixed agglutination. Cancer Res (1968) 1.05
Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia. Blood (1987) 1.04
Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci (2001) 1.02
Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry (2001) 1.02
The management of desmoid tumors. Int J Radiat Oncol Biol Phys (1993) 1.02
Respiratory muscle involvement in infantile myotonic dystrophy. Arch Pathol (1974) 1.01
Comparative stereology of mouse atria. Tissue Cell (1981) 0.99
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood (1988) 0.99
Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease. Arch Pathol Lab Med (2001) 0.98
Immunotherapy in patients with melanoma. Ann Surg (1973) 0.98
Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease. Cancer Treat Rep (1982) 0.98
Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. J Exp Med (1976) 0.98
The phenotypic diversity of peripheral T-cell lymphomas: the Southeastern Cancer Study Group experience. Hum Pathol (1986) 0.98
Detection and partial characterization of human T and B lymphocyte membrane antigens with antisera to HSB and SB cell lines. J Immunol (1978) 0.98
Molecular characterization of a mucin-type antigen associated with human pancreatic cancer. The DU-PAN-2 antigen. J Biol Chem (1987) 0.98
Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients. Cancer Res (1988) 0.97
Exfoliative cytopathologic studies in organ transplantation. I. The cytologic diagnosis of cytomegalic inclusion disease in the urine of renal allograft recipients. Am J Clin Pathol (1969) 0.97
HL-A antigenic loss in malignant transformation. J Natl Cancer Inst (1971) 0.97
Co-expression of human cancer-associated epitopes on mucin molecules. Int J Cancer (1987) 0.95
The accuracy of combined cytopathologic and flow cytometric analysis of fine-needle aspirates of lymph nodes. Am J Clin Pathol (2000) 0.94
Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas (1989) 0.94
Human tumor-specific cytotoxic T cell lines generated from tumor-draining lymph node infiltrate. Transplant Proc (1988) 0.94
Adenoid cystic carcinoma of the breast metastatic to the kidney. A clinically symptomatic lesion requiring surgical management. Cancer (1991) 0.94
A rapid method of staining ultrathin sections for surgical pathology TEM with the use of the microwave oven. Am J Clin Pathol (1985) 0.93
Acute pancreatitis in an infant with lactic acidosis and a mutation at nucleotide 3243 in the mitochondrial DNA tRNALeu(UUR) gene. Eur J Pediatr (1996) 0.93
Production of HL-A-specific antibodies in monkeys by immunization with soluble HL-A-antigens. Transplantation (1972) 0.93
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol (1999) 0.92
Characterization of the human tumor and normal tissue reactivity of the KS1/4 monoclonal antibody. Hybridoma (1988) 0.92
Immunocytochemical detection of lymphocyte surface antigens in fixed tissue sections. J Histochem Cytochem (1982) 0.92
Detection and partial characterization of human thymus-leukemia antigens. J Natl Cancer Inst (1980) 0.92
Isolated deficiency of vitamin E with progressive neurologic deterioration. Neurology (1987) 0.92
Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia. J Clin Oncol (1993) 0.92
T-cell lymphoma mimicking granulocytic sarcoma. Am J Clin Pathol (1985) 0.92
Characterization of high and low molecular weight lymphocyte-activating factor (interleukin I) from P388D and J774.1 mouse macrophage cell lines. J Reticuloendothel Soc (1980) 0.92
Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Int J Cancer (1988) 0.92
Comparative stereology of the lizard and frog myocardium. Tissue Cell (1984) 0.91
Ten years of respiratory cytopathology at Duke University Medical Center. I. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol (1981) 0.91
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia (1999) 0.91
Localization of functionally different guinea-pig spleen cells in albumin gradients. Immunology (1972) 0.91
Platelet-activating factor induces airway mucin release via activation of protein kinase C: evidence for translocation of protein kinase C to membranes. Am J Respir Cell Mol Biol (1994) 0.91
A simple, effective method for the construction of subtracted cDNA libraries. Genet Anal Tech Appl (1991) 0.91
Characterization and distribution of a 24,000-molecular weight antigen defined by a monoclonal antibody (DU-ALL-1) elicited to common acute lymphoblastic leukemia (cALL) cells. Leuk Res (1982) 0.90
Long-term culture and characterization of alloreactive T-cell infiltrates from renal needle biopsies. Hum Immunol (1985) 0.89
Consistency of isochromosome 7q and trisomy 8 in hepatosplenic gammadelta T-cell lymphoma: detection by fluorescence In situ hybridization of a splenic touch-preparation from a pediatric patient. Pediatr Dev Pathol (1999) 0.89
Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol (1998) 0.89
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (1998) 0.89
Renal allografts in HL-A matched recipients. Light, immunofluorescence and electron microscopic studies. Am J Pathol (1970) 0.89
Quantitative analysis of the change of metabolite fluxes along the pentose phosphate and glycolytic pathways in Tetrahymena in response to carbohydrates. J Biol Chem (1977) 0.88
Interferon-gamma induces the synthesis and activation of cytosolic phospholipase A2. J Clin Invest (1994) 0.88